The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
Abstract
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In animal models, fumarate hydratase inactivation induces a precancerous phenotype associated with chronic HIF pathway activation, highlighting the intersection of mitochondrial metabolism, redox homeostasis, and HIF regulation [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“These metabolic perturbations, which are tightly linked to altered cellular redox balance, result in pseudohypoxic signaling and increased cancer susceptibility [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“Mitochondrial dysfunction could impair oxidative phosphorylation, the TCA cycle, fatty acid oxidation, the urea cycle, gluconeogenesis, and apoptotic pathways (King et al., 2006; Modica-Napolitano and Singh, 2004).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as King et al., 2006
In the citing paper
“Loss-of-function mutations in SDH and FH cause a build-up of succinate and fumarate, respectively87. Accordingly, increased levels of succinate and fumarate caused by mutations in these genes can compete with αKG and inhibit activity of HIF hydroxylases and thus induce normoxic HIF1α activity in vitro88,89.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [87]
In the citing paper
“Interestingly, inherited mutations in fumarate hydratase, another Krebs cycle enzyme, have also been linked to a separate and equally rare inherited cancer syndrome 96 .”
From The common biology of cancer and ageing (2007) · cites this paper as [96]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“Although both molecules were shown to mediate HIF induction (Isaacs et al., 2005; Selak et al., 2005), it is possible that they inhibit different PHDs with different efficiency.”
BackgroundInfluentialSelf-citationOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Moreover, enhanced glucose breakdown provides building blocks for the synthesis of nucleotides (via the pentose phosphate pathway), and amino and fatty acids (from glycolytic and TCA cycle intermediates) (Figure 1) (Owen et al., 2002).”
BackgroundOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“These are reactive oxygen species (ROS), which can be generated by the ETC, especially in complex I and III (Raha and Robinson, 2000).”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K. (2004) · Nature Genetics · doi:10.1038/ng1494 · Cited by 980
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–674 of 674
Functional networks of events that modulate phenotypic manifestation of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.012
Mutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
Hypoxia‐Inducible Factor 1 (HIF‐1) Mediated Adaptive Responses in the Solid Tumor
Golias, T., & Denko, N. C. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch12
Cellular Respiration and Dedifferentiation
Scatena, R., Bottoni, P., & Giardina, B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_4
Mitochondrial Function in Lung Health and Disease
Puente‐Maestu, L., & Chancafe-Morgan, J. (2014) · Respiratory medicine · doi:10.1007/978-1-4939-0829-5_8
Li, Y. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1404.3604
The Role of IDH1 and IDH2 Mutations in Malignant Gliomas
Sonoda, Y., Shibahara, I., Saito, R., Kumabe, T., & Tominaga, T. (2011) · Springer eBooks · doi:10.1007/978-94-007-0618-7_6
The enzyme succinate dehydrogenase (SDH) and its role in hereditary pituitary adenomas
Панкратова, Ю. В., Przhiyalkovskaya, E. G., Pigarova, E. A., & Dzeranova, L. K. (2013) · Obesity and metabolism · doi:10.14341/omet2013410-15
Novel findings in intermediary metabolism regulation
Wang, Q., & Zhao, S. (2010) · Chinese Science Bulletin · doi:10.1007/s11434-010-4038-y
Otto Warburg's contributions to current concepts of cancer metabolism
Butenandt, A. (2011)
Role of SIRT6 in Metabolic Reprogramming During Colorectal Carcinoma
Sebastián, C. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada614181
Metabolism and Motility: Characterizing Metabolic Changes that Lead to Metastasis.
Wassenhove, V., & Wassenhove, L. D. V. (2013)
Løland, K. H. (2014) · NORA - Norwegian Open Research Archives
Metabolômica da resistência ao metotrexato na leucemia linfóide aguda
Canevarolo, R. R. (2012) · doi:10.47749/t/unicamp.2012.842040
Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours
Backman, S., & Björklund, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_6
Molecular Genetics of Pheochromocytoma and Paraganglioma
Robledo, M., Currás-Freixes, M., & Cascón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_2
Bruchelt, G., Handgretinger, R., Weckenmann, M., & Hahn, T. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_5
Nitric oxide cytotoxicity and functions of iron-sulfur enzymes in Escherichia coli
Ren, B. (2009) · Louisiana State University · doi:10.31390/gradschool_dissertations.3786
Philip, B. (2014) · Griffith Research Online · doi:10.25904/1912/1367
Zhao, F. L. (2014) · UA Campus Repository (The University of Arizona)
Ferenchuk, Y., & Bevzo, V. V. (2018) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs03.05.049
Impact of hypoxia on hepatitis B virus replication
Frampton, N. R. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Yamakura, M. U. F. (2012)
Type 2B von Hippel-Lindau disease: molecular biology, tumor growth, and development
Lee, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/29tv-bb60
Metabolite-Sensing and Human Diseases
Zhao, S., & Zhao, J. (2016) · Scientia Sinica Vitae · doi:10.1360/n052016-00133
Peculiarity of iron metabolism and its role in carcinogenesis processes
Lugovskiy, S. P., Lubyanova, I. P., & Klymenko, P. P. (2013) · Ukrainian Journal of Occupational Health · doi:10.33573/ujoh2013.02.055
Medical physiological parameter for lead/vaccine testing
Satapathy, A., & Nimesh, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821471-8.00019-2
Villarreal, B., & Nadilly, Y. (2021) · Figshare
Abuja, P. M., Zatloukal, K., & Denk, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212545
Nelson, D. L., & Cox, M. M. (2008) · Springer-Lehrbuch · doi:10.1007/978-3-540-68638-5_16
TSE, C. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.60060
Targeting ROS Induced Epigenetic Reprograming in Cancer Stem Cells
Koul, H. K., Saikolappan, S., Kumar, B., & Koul, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_69-1
Oncometabolites, epigenetic marks, and DNA repair
Dow, J., & Glazer, P. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91081-1.00008-x
Targeting ROS-Induced Epigenetic Reprograming in Cancer Stem Cells
Koul, H. K., Saikolappan, S., Kumar, B., & Koul, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_69
Glyoxal‑induced disruption of tumor cell progression in breast cancer
Rong, P., Li, Y., Nianchun, G., Qi, L., & Li, X. (2023) · Molecular and Clinical Oncology · doi:10.3892/mco.2023.2622
Абдуразакович, Х. Р., Джафарова, А. М., & Абдуллаев, В. Р. (2022) · BIOPHYSICS · doi:10.1134/s0006350922060094
Data from Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., & McCreath, K. J. (2023) · doi:10.1158/0008-5472.c.6497447
Succinate as an Oncometabolite in Endocrine, Mesenchymal, and Epithelial Tumors
Yazdi, S. A. M., & Nazar, E. (2022) · Iranian Red Crescent Medical Journal · doi:10.32592/ircmj.2022.24.12.2395
Data from Altered Dynamics of Intestinal Cell Maturation in Apc1638N/+ Mice
Wang, D., Pezo, R. C., Corner, G. A., Sison, C. P., LESSER, M. L., Shenoy, S. M., Mariadason, J. M., Singer, R. H., & Augenlicht, L. H. (2023) · doi:10.1158/0008-5472.c.6500448
Fisetinidin chloride ameliorates carbon tetrachloride-induced hepatotoxicity in HepaRG cells
Wang, Z.-B., Zhai, Y.-Z., Deng, W., Bai, X.-L., Long, Y., Ullah, K., Sammad, A., & Feng, J. (2025) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-025-10080-z
Saucedo-Rodríguez, M. J., Pecina, P., Tauchmannová, K., Čunátová, K., Vrbacký, M., Čajka, T., Houštěk, J., Mráček, T., & Pecinová, A. (2026) · Research Square · doi:10.21203/rs.3.rs-8568560/v1 · Cited by 1
Saeed, S., Khan, S., Noor, A., Zerr, I., & Zafar, S. (2026) · Molecular Informatics · doi:10.1002/minf.70024
Modeling the respiratory chain and the oxidative phosphorylation
Heiske, M. (2012) · theses.fr (ABES) · doi:10.70675/912cc242z46f1z4fbfzaa7fz8fccf4963d21
Targeting the metabolic environment to modulate T cell effector function
Matias, M. I. (2019) · theses.fr (ABES) · doi:10.70675/0582ddaaze61dz4707z9cb1zdb8fe1d82653
Leventoux, N. (2018) · theses.fr (ABES) · doi:10.70675/1b8ddd02z3a93z40cdz9da9z8c69201d9db7
Stage-specific changes in the Krebs cycle network regulate human erythroid differentiation
Romano, M. (2018) · theses.fr (ABES) · doi:10.70675/4312681cz0207z4923zb100z879f8a73681c
A metabolic crosstalk between liposarcoma and skeletal muscle sustains tumor growth
Romero, J. P. (2020) · theses.fr (ABES) · doi:10.70675/4cf2e124zfd6ez42dazb9baz3a6f801f1847
Deciphering the metabolic bases of Drosophila intestinal tumors
Delamotte, P. (2024) · theses.fr (ABES) · doi:10.70675/c62595f4zbfe2z4ee5zba1az272c10f57e2a
Guo, X., Li, H., Huang, Y., Zhao, L., Wang, Z., Zhu, X., Zeng, P., Huang, Y., Gao, H., Cen, X., et al. (2026) · Toxicology · doi:10.1016/j.tox.2026.154482
The role of mitochondrial proteases in inflammation and immunity
Ferreira, A. R. O., & DAY, E. D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761658
Metabolic regulation and cardiac regeneration
Davé, S. L., & Payumo, A. Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34186-1.00002-5
Cai, L., Jendrossek, V., Matschke, J., & Vega-Rubín-de-Celis, S. (2026) · International review of cytology · doi:10.1016/bs.ircmb.2026.07.005
Kachi, S., Suzuki, K., Hamaguchi, R., Narui, R., Morikawa, H., & Wada, H. (2026) · Cancer Nexus · doi:10.1002/cnx2.70035
Bai, Y., & Chen, W. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1931732
Metabolic regulation of calcium homeostasis via SERCA succination
Ham, S. J., Kim, Y., Kim, S., Bang, S., Koh, Y. H., Roh, S., Park, H. S., & Chung, J. (2026) · Science Advances · doi:10.1126/sciadv.aeh2771
Tian, Y., Ma, S., Yang, B., Gao, F., Guo, H., Liu, H., Wu, X., Cui, W., Dong, J., Lin, Q., et al. (2026) · Advanced Science · doi:10.1002/advs.77698
A case study of triple-negative breast cancer in a 23-year-old with co-mutations in SDHB and BRCA1
Keaton, A. B., Tillinghast, G. W., Lloyd, J., Fattah, K., & Lauro, C. F. (2026) · Current Problems in Cancer Case Reports · doi:10.1016/j.cpccr.2026.100447
Fumarate and Its Esters: Physiology, Pathology, Molecular Mechanisms, Diseases, and Therapy
Zhu, P., You, M., Zeng, Y., Zhang, J., Chen, S., Rong, R., & Xia, X. (2026) · MedComm · doi:10.1002/mco2.71059
BindingDB (2013) · UC San Diego · doi:10.7270/q26q1zjv
Integrative Pro-angiogenic Activation: HIF-α
Vincent, K. A., & Kelly, R. A. (2007) · Springer eBooks · doi:10.1007/1-4020-5955-8_7
Metadata
- Authors
- King, A., Selak, M. A., & Gottlieb, E.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Gottlieb, E
- Venue
- Oncogene
- Published
- 2006-08-07
- Volume
- 25
- Issue
- 34
- Pages
- 4675-4682
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2005828644
- Semantic Scholar
- 960f2f114b8beb17db8bd6d91cd79f788b80738a
- Cited by
- 672
- References
- 61
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 42 · 2021: 39 · 2020: 38 · 2019: 37 · 2018: 37 · 2017: 42 · 2016: 39 · 2015: 37 · 2014: 42 · 2013: 37 · 2012: 52
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- succinate dehydrogenase, fumarate hydratase, mitochondrial dysfunction, tumour suppressor, succinic acid, fumarate, metabolic signalling, prolyl hydroxylase inhibition, pseudohypoxia, hypoxia-inducible factor, apoptosis resistance, carcinogenesis
- MeSH terms
- Fumarate Hydratase, Humans, Mitochondria, Neoplasms, Succinate Dehydrogenase, Genes, Tumor Suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
